Key Takeaways
- • European deep tech secured $3.6 billion in Q2 2023, ranking as the second most-invested sector after energy, signaling recovery after a slowdown in Q1 2023.
- • Annual deep tech funding in Europe reached $18 billion in 2022, double the 2020 level, though Q1 2023 represented the lowest quarterly performance since Q1 2022, indicating sector volatility.
- • Recent notable fundings include Zibra AI (Ukraine) at $500K, AutogenAI (London) at $22.3 million, and Quench.AI at $5 million, demonstrating continued capital deployment across AI and deep tech subsectors.
- • Ganymed Robotics, a Paris-based surgical robotics developer founded by Sophie Cahen, has raised $44.6 million total funding including a €15 million Series B extension in 2022, exemplifying AI-driven healthcare innovation in Europe.
- • Deep tech subsectors including quantum computing, space technology, robotics, and artificial intelligence are transitioning from staging phases toward maturity and commercialization after years of foundational development.
Summary
European deep tech is emerging as a sustained investment priority following years of sector maturation across quantum computing, space technology, robotics, and artificial intelligence. After being overshadowed by consumer-focused ventures and speculative asset classes offering faster returns, deep tech has resurged as a leading vertical in Europe's venture capital landscape.
Funding patterns reveal both volatility and underlying strength. European deep tech attracted $18 billion in venture capital during 2022—a modest decline from 2021 but representing a doubling of 2020 investment levels. The sector experienced a contraction in Q1 2023, which Dealroom identified as the lowest quarterly performance since Q1 2022. However, momentum accelerated in Q2 2023, when deep tech companies secured $3.6 billion, positioning the sector as the second most-invested vertical after energy. This recovery suggests renewed institutional confidence despite broader venture capital market headwinds.
Recent funding activity demonstrates active capital deployment across AI and deep tech companies. Ukrainian startup Zibra AI secured $500,000, London-based AutogenAI raised $22.3 million, and Quench.AI closed a $5 million round, collectively reflecting investor appetite for AI-driven applications across geographies. Ganymed Robotics, a Paris-based developer of AI-powered surgical robotics for orthopedic procedures, exemplifies the sector's commercial momentum. Founded in 2018 by Sophie Cahen, Ganymed has accumulated $44.6 million in total funding, including a €15 million Series B extension in 2022. The company focuses on co-manipulated surgical robotic assistants for Total Knee Arthroplasty (TKA), offering surgeons enhanced precision through compact, workflow-integrated technology.
The deep tech sector's transition from research and development phases toward commercialization reflects maturing subsector fundamentals across quantum, space, robotics, and AI domains. This inflection point signals a structural shift in European venture capital allocation toward capital-intensive, longer-duration investment horizons as these technologies approach profitability and market adoption.
Funding patterns reveal both volatility and underlying strength. European deep tech attracted $18 billion in venture capital during 2022—a modest decline from 2021 but representing a doubling of 2020 investment levels. The sector experienced a contraction in Q1 2023, which Dealroom identified as the lowest quarterly performance since Q1 2022. However, momentum accelerated in Q2 2023, when deep tech companies secured $3.6 billion, positioning the sector as the second most-invested vertical after energy. This recovery suggests renewed institutional confidence despite broader venture capital market headwinds.
Recent funding activity demonstrates active capital deployment across AI and deep tech companies. Ukrainian startup Zibra AI secured $500,000, London-based AutogenAI raised $22.3 million, and Quench.AI closed a $5 million round, collectively reflecting investor appetite for AI-driven applications across geographies. Ganymed Robotics, a Paris-based developer of AI-powered surgical robotics for orthopedic procedures, exemplifies the sector's commercial momentum. Founded in 2018 by Sophie Cahen, Ganymed has accumulated $44.6 million in total funding, including a €15 million Series B extension in 2022. The company focuses on co-manipulated surgical robotic assistants for Total Knee Arthroplasty (TKA), offering surgeons enhanced precision through compact, workflow-integrated technology.
The deep tech sector's transition from research and development phases toward commercialization reflects maturing subsector fundamentals across quantum, space, robotics, and AI domains. This inflection point signals a structural shift in European venture capital allocation toward capital-intensive, longer-duration investment horizons as these technologies approach profitability and market adoption.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.